日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD

对于接受伊布替尼治疗≥1年的高危慢性淋巴细胞白血病(CLL)患者,维奈托克巩固治疗可显著降低微小残留病灶(MRD)的检出率。

Thompson, Philip A; Keating, Michael J; Ferrajoli, Alessandra; Jain, Nitin; Peterson, Christine B; Garg, Naveen; Wang, Sa A; Jorgensen, Jeffrey L; Kadia, Tapan M; Bose, Prithviraj; Pemmaraju, Naveen; Short, Nicholas J; Wierda, William G

Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphoma

独特的病理特征和基因表达谱可将母细胞样高级别B细胞淋巴瘤与B细胞急性淋巴细胞白血病/淋巴瘤区分开来。

Qiu, Lianqun; Xu, Jie; Lin, Pei; Cohen, Evan N; Tang, Guilin; Wang, Sa A; Khanlari, Mahsa; Wang, Wei; Khoury, Joseph D; Konoplev, Sergej; Yin, C Cameron; Jorgensen, Jeffrey L; Vega, Francisco; Medeiros, L Jeffrey; Li, Shaoying

High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse

高灵敏度二代测序微小残留病(MRD)检测在急性淋巴细胞白血病(ALL)中可识别复发风险极低的患者。

Short, Nicholas J; Kantarjian, Hagop; Ravandi, Farhad; Konopleva, Marina; Jain, Nitin; Kanagal-Shamanna, Rashmi; Patel, Keyur P; Macaron, Walid; Kadia, Tapan M; Wang, Sa; Jorgensen, Jeffrey L; Khoury, Joseph D; Yilmaz, Musa; Kebriaei, Partow; Takahashi, Koichi; Garcia-Manero, Guillermo; Daver, Naval; Post, Sean M; Huang, Xuelin; Kornblau, Steven M; Pelletier, Sara; Flores, Wilmer; Matthews, Jairo; Garris, Rebecca; Jabbour, Elias

Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm

对反应性和肿瘤性浆细胞样树突状细胞进行免疫表型鉴定,可以建立一个10色流式细胞术检测组合,用于浆细胞样树突状细胞肿瘤的初步检查和残留病灶评估。

Wang, Wei; Khoury, Joseph D; Miranda, Roberto N; Jorgensen, Jeffrey L; Xu, Jie; Loghavi, Sanam; Li, Shaoying; Pemmaraju, Naveen; Nguyen, Than; Medeiros, L Jeffrey; Wang, Sa A

Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis

Hyper-CVAD联合奥法妥木单抗对比Hyper-CVAD联合利妥昔单抗作为费城染色体阴性急性淋巴细胞白血病成人患者一线治疗方案的倾向评分分析

Sasaki, Koji; Kantarjian, Hagop M; Morita, Kiyomi; Short, Nicholas J; Konopleva, Marina; Jain, Nitin; Ravandi, Farhad; Garcia-Manero, Guillermo; Wang, Sa; Khoury, Joseph D; Jorgensen, Jeffrey L; Champlin, Richard E; Khouri, Issa F; Kebriaei, Partow; Schroeder, Heather M; Khouri, Maria; Garris, Rebecca; Takahashi, Koichi; O'Brien, Susan M; Jabbour, Elias J

Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide

单倍体相合造血干细胞移植中,骨髓移植与外周血移植联合移植后环磷酰胺治疗的比较

Mehta, Rohtesh S; Saliba, Rima M; Alsfeld, Leonard C; Jorgensen, Jeffrey L; Wang, Sa A; Anderlini, Paolo; Al-Atrash, Gheath; Bashir, Qaiser; Ciurea, Stefan O; Hosing, Chitra M; Im, Jin S; Kebriaei, Partow; Khouri, Issa; Marin, David; Nieto, Yago; Olson, Amanda; Oran, Betul; Popat, Uday R; Qazilbash, Muzaffar H; Ramdial, Jeremy; Rondon, Gabriela; Saini, Neeraj; Srour, Samer A; Rezvani, Katayoun; Shpall, Elizabeth J; Champlin, Richard E; Alousi, Amin M

Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia

NPM1突变型急性髓系白血病患者缓解期骨髓中持续性克隆性造血的流式细胞术免疫表型改变

Loghavi, Sanam; DiNardo, Courtney D; Furudate, Ken; Takahashi, Koichi; Tanaka, Tomoyuki; Short, Nicholas J; Kadia, Tapan; Konopleva, Marina; Kanagal-Shamanna, Rashmi; Farnoud, Noushin R; Pierce, Sherry; Khoury, Joseph D; Jorgensen, Jeffrey L; Patel, Keyur P; Daver, Naval; Yilmaz, Musa; Medeiros, L Jeffrey; Kantarjian, Hagop; Ravandi, Farhad; Wang, Sa A

Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML

复发或难治性急性髓系白血病患者完全缓解伴微小残留病灶阴性的预后影响

Short, Nicholas J; Rafei, Hind; Daver, Naval; Hwang, Hyunsoo; Ning, Jing; Jorgensen, Jeffrey L; Kadia, Tapan M; DiNardo, Courtney D; Wang, Sa A; Jabbour, Elias; Popat, Uday; Oran, Betul; Cortes, Jorge; Konopleva, Marina; Yilmaz, Musa; Issa, Ghayas C; Kantarjian, Hagop; Ravandi, Farhad

Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

阿扎胞苷联合纳武利尤单抗治疗复发/难治性急性髓系白血病的疗效、安全性及反应生物标志物:一项非随机、开放标签的II期研究

Daver, Naval; Garcia-Manero, Guillermo; Basu, Sreyashi; Boddu, Prajwal C; Alfayez, Mansour; Cortes, Jorge E; Konopleva, Marina; Ravandi-Kashani, Farhad; Jabbour, Elias; Kadia, Tapan; Nogueras-Gonzalez, Graciela M; Ning, Jing; Pemmaraju, Naveen; DiNardo, Courtney D; Andreeff, Michael; Pierce, Sherry A; Gordon, Tauna; Kornblau, Steven M; Flores, Wilmer; Alhamal, Zainab; Bueso-Ramos, Carlos; Jorgensen, Jeffrey L; Patel, Keyur P; Blando, Jorge; Allison, James P; Sharma, Padmanee; Kantarjian, Hagop

Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy

下一代测序无法检测到的微小残留病灶预示着化疗免疫治疗后慢性淋巴细胞白血病患者的预后改善

Thompson, Philip A; Srivastava, Jaya; Peterson, Christine; Strati, Paolo; Jorgensen, Jeffrey L; Hether, Tyler; Keating, Michael J; O'Brien, Susan M; Ferrajoli, Alessandra; Burger, Jan A; Estrov, Zeev; Jain, Nitin; Wierda, William G